KZR – kezar life sciences, inc. (US:NASDAQ)
Stock Stats
News
Kezar Life Sciences, Inc. (NASDAQ: KZR) had its price target lowered by analysts at Wells Fargo & Company from $11.00 to $9.00. They now have an "equal weight" rating on the stock.
Kezar Life Sciences, Inc. (NASDAQ: KZR) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Kezar Life Sciences, Inc. (NASDAQ: KZR) had its price target lowered by analysts at Wells Fargo & Company from $20.00 to $11.00. They now have an "equal weight" rating on the stock.
Kezar Life Sciences, Inc. (NASDAQ: KZR) had its "market perform" rating re-affirmed by analysts at William Blair.
Kezar Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Form 8-K Kezar Life Sciences, For: Dec 03
Form 8-K Kezar Life Sciences, For: Nov 13
Form SCHEDULE 13G/A Kezar Life Sciences, Filed by: BARCLAYS PLC
Form 10-Q Kezar Life Sciences, For: Sep 30
Form 8-K Kezar Life Sciences, For: Nov 12
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.